/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Lisata Therapeutics Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$1.95 0.0132(1.32%) LSTA at 04 Dec 2025 04:37 PM Biotechnology
Lowest Today 1.91
Highest Today 1.95
Today’s Open 1.95
Prev. Close 1.9
52 Week High 4.20
52 Week Low 1.81
Day’s Range: Low 1.91 High 1.95
52-Week Range: Low 1.81 High 4.20
1 day return -
1 Week return -
1 month return -14.22
3 month return -8.92
6 month return -21.96
1 year return -28.15
3 year return -35.8
5 year return -91.75
10 year return -

Institutional Holdings

Vanguard Group Inc 2.90

BML Capital Management LLC 2.40

Vanguard Total Stock Mkt Idx Inv 2.19

Renaissance Technologies Corp 1.17

Geode Capital Management, LLC 0.70

BlackRock Inc 0.63

Vanguard Institutional Extnd Mkt Idx Tr 0.48

Fidelity Extended Market Index 0.43

Dimensional Fund Advisors, Inc. 0.29

State Street Corp 0.16

HPM Partners LLC 0.14

Bank of America Corp 0.12

Northern Trust Corp 0.12

HighTower Advisors, LLC 0.11

Fidelity Series Total Market Index 0.11

Northern Trust Extended Eq Market Idx 0.08

NT Ext Equity Mkt Idx Fd - L 0.08

UBS Group AG 0.08

Spartan Extended Market Index Pool F 0.07

Royal Bank of Canada 0.07

Fidelity Total Market Index 0.05

Dimensional US Equity Market ETF 0.04

DFA US Vector Equity I 0.04

Spartan Total Market Index Pool G 0.04

DFA US Core Equity Class F 0.04

DFA US Targeted Value I 0.03

NT Ext Equity Mkt Idx Fd - NL 0.03

Dimensional US Small Cap ETF 0.03

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.03

DFA US Social Core Equity 2 Portfolio 0.03

Fidelity Nasdaq Composite Index 0.02

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

Founders Capital Management Inc 0.02

Dimensional US Core Equity 2 ETF 0.02

Tower Research Capital LLC 0.02

Morgan Stanley - Brokerage Accounts 0.00

SBI Securities Co Ltd 0.00

Barclays PLC 0.00

Cheviot Value Management, Inc. 0.00

Wells Fargo & Co 0.00

Market Status

Strong Buy: 1

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 16.76 M

PB Ratio 0.9951

PE Ratio 0.0

Enterprise Value -4.63 M

Total Assets 35.00 M

Volume 19167

Company Financials

Annual Revenue FY23:0 0.0M, FY22:121372000 121.4M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:63771000 63.8M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-21465000 -21.5M, FY22:-54225000 -54.2M, FY21:-27466000 -27.5M, FY20:-8141000 -8.1M, FY19:-20101000 -20.1M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:70000 0.1M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:70000 0.1M, Q1/2025:-43000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-45000 -0.0M

Quarterly Net worth Q3/2025:-4249000 -4.2M, Q2/2025:-4659000 -4.7M, Q1/2025:-4724000 -4.7M, Q3/2024:-4930000 -4.9M, Q2/2024:-5044000 -5.0M

Fund house & investment objective

Company Information Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Organisation Biotechnology

Employees 26

Industry Biotechnology

CEO Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow